Scientific program
Some of the programs will be available on-demand streaming after the symposium. On-demand streaming will be delivered from Oct. 16, 2023.
*Patients forum, oreal sessions and poster sessions are only available onsite.
Awardees
Berger Award
- O-01
- Characteristics of kidney resident plasma cells in IgA nephropathy
Yuko Makita (Canada)
Young Investigator Award
- O-03
- Novel IgA autoantibodies against mesangial cells, anti-βII spectrin IgA, is essential for development of IgA nephropathy
Yoshihito Nihei (Japan)
- O-10
- GWAS uncovers novel mechanisms and potential therapeutic targets for IgA vasculitis
Lili Liu (USA)
- O-16
- CARD9 Risk Locus for IgA Nephropathy Regulates Mucosal IgA Production
Patrick J Gleeson (France)
Outstanding Scientist Award
- O-04
- Galactose deficiency alters the structure of IgA1 and mediates IgA1 deposition in the mesangium of patients with IgA nephropathy
Meijun Si (China)
- LB-2
- Effect of corticosteroids on kidney and safety outcomes in IgA nephropathy across different levels of proteinuria and eGFR: A post hoc analysis of the TESTING study
Kim Dana (Australia)
- P-37
- Clinical significance of glomerular and circulating apoptosis inhibitor of macrophage in IgAN nephropathy
Rina Kato (Japan)
- P-45
- Does Female Gender Affect The Prognosis of Patients with IgAN After Kidney Transplant?
Dita Maixnerova (Czech)
Program at a glance
Pre-conference period: September 25-27
- Industry symposium 0 *open for all the delegates
Date & Time: 18:00-19:00, Tuesday, September 26, 2023
ChairYusuke Suzuki (Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo Japan)
SpeakerSean Barbour (University of British Columbia, Division of Nephrology, Vancouver, Canada)
Co-sponsored by: Kyowa Kirin Co., Ltd.
- Closed meetings for a exchange of information between key opinion leaders (KOLs) and industry companies are scheduled during the pre-conference period.
Thursday, September 28
9:30-9:40 | Opening remarks
Venue: 3F KFC Hall |
---|---|
9:40-10:00 | IgAn Network President Lecture
On-Demand Venue: 3F KFC Hall
|
10:00-10:45 | Patients forum
Venue: 3F KFC Hall
|
11:00-12:00 | Oral session1 “Molecular Pathogenesis “
Venue: 3F KFC Hall
Presentation No.: O-01~O-05 |
12:15-13:15 | |
13:45-14:45 | Oral session2 “Genetics and Epigenetics“
Venue: 3F KFC Hall
Presentation No.: O-06~O-10 |
14:35-15:35 | Oral session3 “Biomarkers“
Venue: 3F KFC Hall
Presentation No.: O-11~O-15 |
15:50-16:50 | Oral session4 “Microbiome and Immunology “
Venue: 3F KFC Hall
Presentation No.: O-16~O-20 |
17:00-18:00 | International IgA Nephropathy Network Research Group: collaboration in patient-focused research
Venue: 2F KFC Hall 2nd
|
- Poster viewing (regular submission)
Venue: 10F 10A
Friday, September 29
7:30-8:30 | |
---|---|
8:35-9:50 | Symposium part1 “Recent advance in treatment / international clinical treatment”
On-Demand Venue: 3F KFC Hall
1. PSL (Low-dose Testing) & MMF, HCQ
2. Sparsentan/Atrasentan/Zibotentan & SGLT2i
3. Mucosal targeting therapy ;Gut
4. Mucosa targeting therapy: Upper respiratory mucosa
|
10:00-11:00 | Symposium part2
On-Demand Venue: 3F KFC Hall
1. B cell targeting therapy (Anti-APRIL mAb, Atacicept, CD138)
2. Role of complement and its inhibition in IgAN
Panel Discussion "How do we use all these new drugs, alone or in combination?"
|
11:20-12:35 | Poster presentation (regular submission)
Venue: 10F 10A Pathogenesis 1: P-01 - P-09 Pathogenesis 2: P-10 - P-19 Microbiome + genetics: P-20 - P-29 Biomarkers 1: P-30 - P-38 Biomarkers 2: P-39 - P-47 Diagnosis or prediction: P-48 - P-57 Pathology and complement: P-58 - P-67 Clinical Trial 1: P-68 - P-77 Clinical Trial 2: P-78 - P-87 *9 sessions will take place at the same time |
13:00-14:00 | |
14:30-15:00 | President lecture
On-Demand Venue: 3F KFC Hall
|
15:05-15:45 | Honorary lecture “Life time on IgAN" East Asia & West“
On-Demand Venue: 3F KFC Hall
1. My Journey on the Path to Understanding IgA Nephropathy: From Bench to Bedside
2. Lifetime in IgA Nephropathy
|
16:00-16:40 | Show case of future talent “How to succeed in Nephrology”
Venue: 3F KFC Hall
|
17:00-18:00 |
- Poster viewing (regular submission)
Venue: 10F 10A
Saturday, September 30
7:30-8:30 | |
---|---|
8:30-9:30 | Oral session 5 “Pathology and Complement”
Venue: 3F KFC Hall
”Complement and its Colocalization with Immunoglobulins in the Pathogenesis of IgA Nephropathy”
|
9:30-10:40 | Oral session 6 “Clinical Trial 1”
Venue: 3F KFC Hall
Presentation No.: O-26~O-31 |
10:55-11:55 | Oral session 7 “Clinical Trial 2”
Venue: 3F KFC Hall
Presentation No.: O-32~O-35 |
12:10-13:10 | |
13:30-15:10 | CME Workshop jointly held with JSN/ISN/APSN
On-Demand Supported by an educational grant from Otsuka America Pharmaceutical, Inc. Venue: 3F KFC Hall “International comparison, East vs West”
1. The epidemiology of IgA nephropathy
2. Genetics of IgA nephropathy
3. The pathogenesis of IgAN: Where is pathogenic IgA produced?
4. Pathology of IgA nephropathy: a global perspective
5. Current Treatment and New Insights in IgA Nephropathy
Panel discussion
|
15:20-16:00 | Awards ceremony, Ceremony of changing convenor, Closing remarks and commemorative photo session
Venue: 3F KFC Hall |
- Poster viewing (regular submission)
Venue: 10F 10A